直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

Michael Mann, Ph.D. v. National Review et al.

Michael Mann, Ph.D.

National Review et al.

Along with co-counsel from Williams Lapatto and Cozen O’Connor, represented Dr. Mann in prosecuting defamation claims against defendants Mark Steyn (writing for National Review) and Rand Simberg (writing for Competitive Enterprise Institute) for statements personally attacking Dr. Mann in an effort to denigrate the established scientific consensus that human activity is causing climate change. Secured favorable jury verdict, including punitive damages, against defendants.

Michael Mann, Ph.D. v. National Review et al., 2012-CA-008263-B, DC Superior Court, Judge Irving

Related Practices

Global IP Enforcement, Litigation, and Trials

Related Industries

Communications

Media

Related Experiences

AbbVie Inc., et al. v. Aurobindo Pharma U.S.A., Inc. et al.

AbbVie Inc.

Mylan Pharmaceuticals Inc. et al. v. Biogen MA Inc. et al.

Biogen MA Inc. et al.

Lo v. Quake

Sequenom, Inc. et al

Sandoz, Inc. et al v. Pharmacyclics LLC

Pharmacyclics LLC; Janssen Biotech, Inc.

Incyte Corporation et al. v. Sun Pharmaceutical Industries Limited et al.

Incyte Corporation et al.

Genzyme Corporation et al. v. Novartis Gene Therapies, Inc. et al.

Novartis Gene Therapies, Inc. et al.

AbbVie Inc. v. Amgen Inc.

AbbVie Inc.

Regenxbio, Inc. et al. v. Sarepta Therapeutics, Inc. et al.

Sarepta Therapeutics, Inc. et al.

Koninklijke Philips NV et al. v. Tongfang Global Inc. et al.

Koninklijke Philips NV et al.

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP